TCF4 and nasopharyngeal carcinoma: The interaction between MDSCs and tumor cells is mediated in part by cyclooxygenase‐2 (COX‐2) by activating the β‐catenin/TCF4 pathway, which suggests that inhibition of either COX‐2 or MDSCs may suppress metastasis of nasopharyngeal carcinoma.132